|
HOMEZ expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.16420001311712E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.35739999427432E-09 |
| Normal-vs-Stage2 |
1.420870E-04 |
| Normal-vs-Stage3 |
3.73599995384666E-09 |
| Normal-vs-Stage4 |
6.54699960911387E-10 |
| Stage1-vs-Stage2 |
1.719550E-01 |
| Stage1-vs-Stage3 |
4.366000E-01 |
| Stage1-vs-Stage4 |
3.326100E-02 |
| Stage2-vs-Stage3 |
8.980400E-02 |
| Stage2-vs-Stage4 |
1.485980E-02 |
| Stage3-vs-Stage4 |
1.613600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.34120000952976E-09 |
| Normal-vs-AfricanAmerican |
2.31139999999908E-05 |
| Normal-vs-Asian |
2.66959999994931E-06 |
| Caucasian-vs-AfricanAmerican |
6.890600E-01 |
| Caucasian-vs-Asian |
4.403200E-01 |
| AfricanAmerican-vs-Asian |
3.714400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.14859996461314E-09 |
| Normal-vs-Female |
6.71209998692746E-09 |
| Male-vs-Female |
3.425000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.68760000418544E-08 |
| Normal-vs-Age(41-60Yrs) |
9.69000002459808E-09 |
| Normal-vs-Age(61-80Yrs) |
8.65140004080445E-09 |
| Normal-vs-Age(81-100Yrs) |
2.364100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.102400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.650600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.271770E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.126400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.212210E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.895550E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.436000E-02 |
| Classical-VS-Follicular |
9.543800E-02 |
| Classical-VS-Other |
5.531400E-01 |
| Classical-VS-Normal |
7.95550000320944E-08 |
| Tall-VS-Follicular |
5.983600E-01 |
| Tall-VS-Other |
7.817400E-01 |
| Tall-VS-Normal |
2.04960000083076E-08 |
| Follicular-VS-Other |
9.808000E-01 |
| Follicular-VS-Normal |
7.61030016782627E-10 |
| Other-VS-Normal |
9.497500E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.05919999940463E-08 |
| Normal-vs-N1 |
2.19730000861063E-09 |
| N0-vs-N1 |
6.166200E-02 |
|
|
